(NASDAQ: SANA) Sana Biotechnology's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.93%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.08%.
Sana Biotechnology's earnings in 2026 is -$244,166,000.On average, 12 Wall Street analysts forecast SANA's earnings for 2026 to be -$152,327,625, with the lowest SANA earnings forecast at -$198,762,465, and the highest SANA earnings forecast at -$106,479,892. On average, 11 Wall Street analysts forecast SANA's earnings for 2027 to be -$163,642,781, with the lowest SANA earnings forecast at -$258,914,263, and the highest SANA earnings forecast at -$103,677,789.
In 2028, SANA is forecast to generate -$183,737,859 in earnings, with the lowest earnings forecast at -$256,298,968 and the highest earnings forecast at -$103,677,789.